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Abstract
Urinary tract infections are a major source of morbidity for women and the elderly, with Uropathogenic Escherichia
coli (UPEC) being the most prevalent causative pathogen. Studies in recent years have defined a key anti-
inflammatory role for Interleukin-10 (IL-10) in urinary tract infection mediated by UPEC and other uropathogens. We
investigated the nature of the IL-10-producing interactions between UPEC and host cells by utilising a novel co-
culture model that incorporated lymphocytes, mononuclear and uroepithelial cells in histotypic proportions. This co-
culture model demonstrated synergistic IL-10 production effects between monocytes and uroepithelial cells following
infection with UPEC. Membrane inserts were used to separate the monocyte and uroepithelial cell types during
infection and revealed two synergistic IL-10 production effects based on contact-dependent and soluble interactions.
Analysis of a comprehensive set of immunologically relevant biomarkers in monocyte-uroepithelial cell co-cultures
highlighted that multiple cytokine, chemokine and signalling factors were also produced in a synergistic or
antagonistic fashion. These results demonstrate that IL-10 responses to UPEC occur via multiple interactions
between several cells types, implying a complex role for infection-related IL-10 during UTI. Development and
application of the co-culture model described in this study is thus useful to define the degree of contact dependency
of biomarker production to UPEC, and highlights the relevance of histotypic co-cultures in studying complex host-
pathogen interactions.
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Introduction
Urinary tract infections (UTIs) are a major cause of morbidity,
affecting 40% of women, of which 20% experience at least one
reoccurrence at a later time. Uropathogenic Escherichia coli
(UPEC) accounts for approximately 80% of all cases of acute
UTI such as cystitis and pyelonephritis [1-4], and up to 86% of
asymptomatic infections [5]. Acute UTI can be localised to
distinct areas of infection, predominantly urethritis and cystitis,
with less common but more severe complications sometimes
arising from pyelonephritis and urosepsis. Increasing antibiotic
resistance of UPEC has highlighted a need for different
approaches to combat infection [6,7]. This, in part, has led to
investigations of the immunomodulatory properties of cytokines
produced during UTI. Several cytokines are intimately involved
in the pathogenesis of infection, as reviewed elsewhere [8-11].
The regulatory cytokine, Interleukin-10 (IL-10), which is
produced during UPEC infection in murine models of UTI and
in patients with UPEC cystitis and pyelonephritis, has been a
focus of several recent pathogenesis studies [12-14].
IL-10 regulates immune responses during many infections,
predominantly by shifting immune responses towards a Th2-
centric adaptive immune outcome that may benefit the host,
and sometimes the pathogen [15,16]. IL-10 is produced by a
wide variety of leukocytes [16], and can be secreted by multiple
intracellular trafficking pathways under different conditions [17].
UPEC induces IL-10 in the bladder during acute UTI, and this
has been proposed to down-regulate inflammatory responses
shortly after infection via monocytes/macrophages [12], and
mast cells [18]. These studies combined in vivo analyses of
UTI in mice with bladder transcriptomics to identify active
biological pathways during infection, which were shown to
comprise IL-10 signaling among the top hits in canonical
pathway recognition. These studies also used in vitro cell
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culture assays to demonstrate UPEC-triggered up-regulation of
IL-10 production in monocytes, but not uroepithelial cells [12].
In vivo studies yield valuable insight into disease
pathogenesis. However, analyses of cellular interactions
between microbes and multiple host cell types that can
generate cytokine responses also benefits from in vitro
methodology. In prior studies of UPEC infection, this has
typically used monocultures of uroepithelial cells, monocytes,
macrophages, or neutrophils to investigate cytokine responses
following infection [19-27]. These studies have offered key
insight into cytokine responses to UPEC infection, including
how the bacterium utilizes virulence factors such as α-
hemolysin to inhibit in vitro epithelial cytokine production [28].
Such insight has implications for suppressing the innate
immune response during UTI [29,30]. Co-culture of different
host cell types in various arrangements, which can rely on
stratification and/or co-localisation to generate responses to
external stimuli [31-33], offer further advantages for infection
studies to mimic in vivo responses [12]. Co-ordinated effects of
co-localised cells can lead to synergistic interactions between
epithelial or endothelial cells and phagocytic or immune cells to
drive responses that are not discernable in monocultures
[31,32].
The current study investigated IL-10 and other cytokine
responses in bladder uroepithelial cell and monocyte co-
cultures challenged with UPEC. We sought to define the nature
of the interactions that occur between these two cell types in
response to UPEC, and whether the interactions might
comprise additive, antagonistic or synergistic effects in relation
to cytokine production. We found that human bladder
uroepithelial cells synergize with monocytes in contact-
dependent and soluble interactions to promote the production
of IL-10 and several other biomarkers based on novel
responses that have implications for understanding UTI
pathogenesis.
Materials and Methods
Cell lines and Bacteria
The cell lines used in these experiments were the
immortalised human lines 5637 bladder carcinoma (ATCC
HTB-9), MC116 B-cells (ATCC CRL-1649), Jurkat T-cells
(ATCC TIB-152) and U937 monocytes (ATCC CRL-1593.2). All
cell lines were purchased from the ATCC (USA), and routinely
maintained at low passage number from frozen stocks. For
some experiments, U937 monocytes were matured to
macrophage-like cells using phorbol-12-myristate-13-acetate in
methods as described elsewhere [34]. The UPEC strain used
in this study was the prototype CFT073 strain (ATCC 700928),
originally isolated from a patient with pyelonephritis [35]. This
strain has been used in multiple in vitro and in vivo UPEC
pathogenesis studies [36-39]. Bacteria were routinely grown
from frozen glycerol stocks on LB agar and in LB broth at 37°C
shaking at 200 rpm.
Cell culture
To investigate in vitro host-pathogen interactions, we
routinely used 96-well plate co-cultures in total volumes of 250
μl for infection assays. The routine maintenance and
preparation of cells was performed according to methods as
described in previous studies [12]. In initial assays, we used a
four cell co-culture model (bladder uroepithelial cells, B-cells,
T-cells and monocytes) to investigate the contribution of the
different cell types to the IL-10 responses to UPEC in vitro. In
subsequent assays, we removed or substituted individual cell
types from this model in various combinations, ensuring that
the overall cell numbers and culture media volumes remained
consistent between assays, to investigate the contribution of
specific cell types to the response.
For all assays, cells were infected with UPEC using a MOI of
10 (that equated to a total of 1.5 x 106 cfu per well) unless
otherwise stated. Cell culture supernatants were collected by
centrifugation (500 x g 10 min 4°C) at 5 h after infection, and
were stored at -80°C until ELISA. We used a commercially
available human ELISA kit to quantitate IL-10 protein
(88-7106-88 eBioscience). For co-culture assays that were
based on the physical separation of uroepithelial cells and
monocytes, we used 24-well cell culture plates containing
membrane inserts (0.4 μm pore-size 140620 Nunc). In these
assays, the co-cultures contained total volumes of 500 μL
RPMI1640 per well, and comprised 2 x 105 5637 cells in the
upper insert and/or 1 x 105 U937 cells in the lower well, with
infected wells having an MOI of 10 (3 x 106 cfu/mL). Cultures
were routinely incubated with UPEC for 5 h at 37°C with 5%
CO2. Supernatants were then collected and frozen for
subsequent ELISA or alternative biomarker analysis. Biological
replicates were performed in triplicate (as a minimum) for all
assays, and experiments were repeated at least three times.
Data presented represent pooled data from multiple
independent experiments, as indicated for each figure.
qRT-PCR
We used qRT-PCR to analyse IL-10 mRNA gene expression
in the different co-cultured cell types in vitro following UPEC
infection. For these assays, 24-well plate co-cultures were
prepared using membrane inserts and infected with UPEC for 5
h as described above. Following infection, the supernatants
were collected for biomarker analysis (below), and RNA was
prepared from uroepithelial and monocyte populations using a
commercial RNA extraction kit (732-6820 Bio-Rad). Total RNA
was quantified using a NanoDrop ND-1000 UV-Vis
spectrophotometer (NanoDrop Technologies) and 100 ng of
RNA from each sample was converted to cDNA using oligo DT
primers from a cDNA conversion kit (18080-051 InVitrogen).
Subsequent qPCR was performed to quantify the relative
abundance of IL-10 mRNA transcripts using the Quantifast
SYBR Green PCR kit (204054 Qiagen). The primer sequences
used for the amplification of IL-10 and GAPDH, which was
used as a housekeeper gene, are described elsewhere [12]
and were purchased from Sigma. Reactions were run on a
Roche LightCycler 480, using reaction cycling conditions as
follows: 95 °C for 5 min followed by 45 cycles of [94 °C for 10 s;
63 °C for 30 s; 72 °C for 20 s] and melt-curve analysis. Relative
quantification was performed using ΔCt values in the equation
2.0-[∆Ct] to calculate the relative mRNA expression level of IL-10
in comparison to GAPDH [40-42]. The infection data was
UPEC-Induced Uroepithelial Cell-Monocyte Synergism
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expressed as averaged ratios of GAPDH-normalized IL-10 Ct
values against the non-infected controls. Quintuplicate
biological samples were assayed in technical triplicate. Primer
efficiency for GAPDH was 1.86 and 1.85 for IL-10.
Biomarker analysis
IL-10 levels in initial assays were measured using ELISA, as
per the manufacturer’s instructions. In initial assays, we
discovered a novel synergistic interaction between bladder
uroepithelial cells and monocytes for UPEC-induced IL-10
synthesis. To complement the IL-10 data, we subsequently
undertook a quantitative analysis of a comprehensive set of
biomarkers to better define the extent of synergistic responses
in the infected dual co-culture model. Using supernatants
collected from 24-well insert dual co-cultures infected as
described above, we analysed a panel of 27 human biomarkers
using a BioPlex 27-plex kit (M50-0KCAF0Y BioRad). Biological
replicates (n=8) were collected from three independent
experiments. These data are presented as individual data
points for each biological replicate with a horizontal bar of the
mean to illustrate within-group variance.
Statistics
Welch’s Independent t test was used to analyse mean
cytokine levels for ELISA data with significance level set to p <
0.05. Mean cytokine levels (pg/mL) of qRT-PCR and BioPlex
data that were not normally distributed were compared using a
Mann–Whitney U test. All statistical analyses were carried out
using IBM SPSS Statistics software (Version 20.0), and
GraphPad Prism software package 5.0. Statistical significance
was accepted as p < 0.05.
Results
UPEC-induced IL-10 production in uroepithelial cell co-
culture
In a prior study of UPEC-infected uroepithelial cell-monocyte
co-cultures, monocytes were the predominant cell type
producing IL-10 at the transcriptional level [12]. In the current
study, we performed initial comparisons to examine other
relevant cell types within a four cell co-culture model
comprising uroepithelial cells, monocytes, B- and T-cells and
analysed their effects on UPEC-induced IL-10 protein levels in
co-culture supernatants. Preliminary assays showed that B-
cells secreted basal levels of IL-10, which is consistent with
prior data [43]. The inclusion of B-cells in co-cultures caused
an approximate doubling of IL-10 levels and the proportional
increases were equal in control and UPEC infected conditions
(Figure S1A). These data led us to exclude B-cells from
subsequent co-cultures. In dual and triple co-cultures of
uroepithelial cells, monocytes and T-cells, in which the cells
were combined in various groupings using 1.5-1.65 x 105 total
cells per well (89:10:1 ratio), we found significant increases in
IL-10 in response to UPEC infection, as shown in Figure 1A. In
these assays, dual co-cultures of monocytes and T-cells had a
total cell number of 1.5-1.65 x 104 cells per well; in
monocultures, the cell numbers used were equivalent to those
used in co-cultures (i.e. ~105 uroepithelial cells, ~104
monocytes, 103 T-cells). All monocultures and co-cultures
containing monocytes produced ≥16 pg/mL IL-10 in response
to infection (Figure 1A). This was significantly less than
monocyte co-cultures containing uroepithelial cells, which
produced 32-34 pg/mL in response to infection (p < 0.001;
Figure 1A). The presence of T-cells in these co-cultures did not
cause any increase in IL-10 levels. All other co-culture
combinations not shown in Figure 1A (excluding those with B-
cells) exhibited IL-10 levels below the detection limit of the
assay (2 pg/mL) (Controls shown in Figure S1B). Collectively,
these data show a previously undescribed synergistic
interaction between uroepithelial cells and monocytes for
UPEC-induced IL-10 production; i.e. uroepithelial cells in
monoculture do not produce IL-10 in response to UPEC
infection, however the addition of monocytes to uroepithelial
cells doubles the response of monocytes alone to UPEC
infection. Based on the synergistic effect between uroepithelial
cells and monocytes, we excluded T-cells from subsequent
assays.
Synergism for IL-10 production in monocyte vs.
macrophage uroepithelial co-cultures
Given the heightened response of macrophages for cytokine
production in general compared to monocytes [44], we
analysed the effect of maturing the monocytes towards IL-10
production in UPEC-infected co-cultures. These data, shown in
Figure 1B, showed stronger IL-10 synthesis in macrophage-
containing co-cultures compared to monocyte co-cultures
following infection (≥ 200 pg/mL vs 16-35 pg/mL; compare
Figure 1AB). Importantly, however there was no statistically
significant difference between the IL-10 levels in the infected
macrophage monocultures and macrophage-uroepithelial cell
co-cultures, indicating that the synergistic effect for UPEC-
triggered IL-10 is restricted to monocyte-uroepithelial co-
cultures; i.e. no significant synergistic phenotype for IL-10
synthesis occurs in macrophage-uroepithelial cell co-cultures.
Contact-dependency of uroepithelial cell-monocyte
synergistic IL-10 responses
In further characterizing the uroepithelial cell-monocyte dual
co-culture model, the cell ratios were next adjusted to a 70:30
ratio of uroepithelial cells:monocytes in 96-well plates (rather
than 90:10), to mimic inflammatory conditions of infected
bladder that are known to encompass a monocyte cellular
infiltrate [45] and extensive monocyte transcriptional
antibacterial responses [46,47] (and unpublished data).
Detailed assays using these cell ratios yielded similar results
for IL-10, with a proportional increase in IL-10 responses in
infected versus control co-cultures (data not shown). This
70:30 dual co-culture model was then applied to 24-well
membrane insert culture conditions to determine whether the
synergistic IL-10 response to UPEC infection depended on
contact between uroepithelial cells and monocytes. Insert-
containing co-cultures routinely comprised uroepithelial cells in
the upper compartment, and/or monocytes in the lower
compartment, as illustrated in the schematic wells depicted in
Figure 2. In these assays, non-infected monocytes produced
UPEC-Induced Uroepithelial Cell-Monocyte Synergism
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low levels of IL-10 (2-3 pg/mL at detection limit of the assay),
which increased to 20 ± 3 pg/mL in infected monocyte
monocultures (Figure 2). Infection of insert-containing wells
was performed by adding UPEC to the upper compartment
(uroepithelial cells), lower compartment (monocytes), or both.
In all of these conditions, IL-10 nearly doubled in production to
Figure 1.  Different cellular combinations reveal synergism between uroepithelial cells and monocytes for UPEC-induced
IL-10 synthesis.  (A) Uroepithelial cells and monocytes in 96 well microtitre plate co-cultures produced peak levels of IL-10 protein
(32-34 pg/mL) compared to monocultures that yielded 16-17 pg/mL following infection. T-cells did not increase IL-10 levels. (B)
Substitution of monocytes with macrophages showed much higher levels of IL-10 with or without uroepithelial cells (> 200 pg/mL),
but there was no significant difference between the two infected conditions (all infected groups significantly above controls, p ≤
0.001; monocyte monocultures vs. monocyte co-cultures with uroepithelial cells, * p = 0.002; macrophage monocultures vs
macrophage-uroepithelial dual co-cultures, ‡ p = 0.003; SEM bars). (Mon = monocyte, Ep = uroepithelial cell, T = T-cell, MΦ =
macrophage, Control = uninfected cells).
doi: 10.1371/journal.pone.0078013.g001
UPEC-Induced Uroepithelial Cell-Monocyte Synergism
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e78013
approximately 35 pg/mL; the levels were similar regardless of
which compartment(s) were infected. In infected dual co-
cultures without inserts, IL-10 levels increased to 65 pg/mL
(Figure 2). Upper compartment infection of uroepithelial cell
monocultures resulted in no significant IL-10 levels (Figure
S1C). Together, these data show that both contact-dependent
and soluble signalling mechanisms between uroepithelial cells
and monocytes (i.e. UPEC cannot pass through inserts)
promote synergistic induction of IL-10 in response to UPEC.
IL-10 mRNA expression in UPEC-infected uroepithelial
cell monocyte co-cultures
To determine whether monocytes are the cell type
responsible for producing IL-10 in the cell separation model, as
was previously reported in non-separated dual co-cultures [12],
we undertook a transcriptional analysis. For this, control and
UPEC-infected dual co-cultures containing inserts were used
for qRT-PCR assay for IL-10 and housekeeper GAPDH gene
transcripts. These data demonstrated that monocytes had a
significantly higher abundance of IL-10 transcripts compared to
uroepithelial cells (Figure 3A; p ≤ 0.001, compare average
cycle number of crossover threshold), and produced effectively
all of the IL-10 mRNA in this model (Figure 3B). There were
significant increases in IL-10 mRNA expression in infected
versus non-infected monocytes under conditions where either
the upper insert, or lower wells, or both were infected (81-98%
increase, equivalent to a 1.8-fold increase on average
comparing non-infected to infected monocyte conditions; p ≤
0.009). In contrast, there were no significant differences in the
levels of IL-10 mRNA expression (a 1.16 fold increase on
average comparing non-infected to infected uroepithelial cell
conditions). Amplification efficiencies of the primers for the
different target sequences were within +/- 10% of each other
using the assay conditions as described (1.85 vs. 1.86). Thus,
monocytes contribute effectively all of the IL-10 transcriptional
responses in this co-culture model.
Biomarker panel analysis of UPEC-induced
uroepithelial cell-monocyte synergism
BioPlex assays of insert-containing and no-insert dual co-
cultures targeting 27 human cytokines, chemokines and growth
factors were used to characterize the extent of synergistic
interactions within the cultures. These assays yielded
numerous interesting response patterns, shown in Figures 4-7.
Additional data that are not shown in these Figures are
presented as Figures S2-S3 (e.g. biomarker responses in
infected monocultures that simply had higher levels than
uninfected controls). A summary of significant synergistic and
antagonistic interactions in these assays are listed in Table 1
(infected co-cultures), and Table 2 (non-infected co-cultures).
Figure 2.  Use of membrane inserts demonstrates contact-dependent IL-10 synergism in UPEC-infected uroepithelial cell-
monocyte dual co-cultures.  The level of IL-10 produced in co-cultures where uroepithelial cells and monocytes were in contact
was double that of cultures where inserts were used to physically separate the two cell types. The schematics below graph show the
cell type, infection and presence of inserts; blue = non-infected, red = infected (all control vs infected groups, p < 0.001; monocyte
monocultures vs insert-containing dual co-cultures, * p ≤ 0.024; insert-containing dual co-cultures vs no insert dual co-cultures, † p ≤
0.002; SEM bars).
doi: 10.1371/journal.pone.0078013.g002
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The data from these assays showed that biomarker
responses occurred differentially as a blend of contact-
dependent and soluble factor-mediated responses. The
contact-dependent responses are summarized in Figure 4,
which illustrates this pattern of response for several biomarkers
in addition to IL-10, namely Interleukin-6 (IL-6), Granulocyte
Macrophage-Colony Stimulating Factor (GM-CSF), and
Platelet-Derived Growth Factor-BB (PDGF-BB). The data for
IL-10 also showed that the response as measured by BioPlex
followed parallel trends as detected in ELISA using samples
from independent assays (Figure 4A): i.e. insert-containing
infected dual co-cultures had higher IL-10 levels than monocyte
monocultures, and no insert dual co-cultures had significantly
higher levels compared to insert-containing dual co-cultures.
These data also showed that contact-dependent responses
to UPEC infection were not always synergistic in nature. For
example, the contact-dependent responses noted for IL-6 GM-
CSF and PDGF-BB were antagonistic; in contrast to IL-10 (a
synergistic contact-dependent response pattern). These factors
were produced in significantly lower levels in infected dual co-
cultures without inserts compared to insert-containing co-
cultures (Figure 4B-D; compare Ni-Mon/Ep [lower] with Ic-
Mon/Ep [higher]). Thus, UPEC-triggered production of IL-6,
GM-CSF and PDGF-BB in uroepithelial cell-monocyte dual co-
cultures is inhibited by contact between the two host cell types.
A similar response pattern of contact-dependent antagonism
was noted for G-CSF, but this difference did not reach
statistical significance (Figure S3).
In addition to contact-dependent synergism and antagonism,
other response patterns for some biomarkers were soluble-
dependent. In fact, soluble-dependent interactions were the
most common type of responses noted for the biomarkers
overall. Among the soluble-dependent responses, we noted
three distinct types of increase responses in co-cultures, and
we grouped these according to the level of biomarker
production in (i) uroepithelial cell monocultures, Figure 5; (ii)
monocyte monocultures, Figure 6; and (iii) both monocultures,
Figure 7. Synergistic responses in non-infected co-cultures are
shown in Figure S2, while biomarkers that had no synergistic
responses are presented in Figure S3. We noted that functional
classes of biomarkers were not restricted to any one type of
response pattern. For example, biomarkers related to
recruitment and cell migration, and cell growth/regulation could
follow production patterns of (i), (ii) or (iii). Specific examples
include biomarkers such as IL-1β, IL-1ra, IL-2, Eotaxin and
TNF-α that had patterns of minimal monoculture expression
(Figure 7), but were expressed at higher levels in infected dual
co-cultures (with or without inserts). Examples where co-
cultures had biomarker increases compared to uroepithelial
monocultures included IL-17, IP-10, MCP-1, MIP-1α/β and
RANTES (compare Ic-Ep and Ep p < 0.05; Figure 5). For other
biomarkers, infected uroepithelial monocultures produced the
Figure 3.  IL-10 mRNA responses to UPEC in dual co-cultures that contain membrane inserts are principally monocyte-
derived.  (A) Monocytes in dual co-cultures overall have > 10-fold abundance of IL-10 transcript compared to uroepithelial cells, as
transcripts emerge 3.4 cycles (Ct = 25.0 vs Ct = 28.4) earlier in qPCR (monocyte vs uroepithelial cell Ct values, p = 0.007). (B)
Monocytes from all insert-containing infected conditions showed a statistically significant increase in IL-10 mRNA (1.8-fold increase
of averaged infected monocyte conditions over control non-infected monocytes; insert-containing infected monocytes from dual co-
cultures vs uninfected control, * p = 0.009). Uroepithelial cells from insert-containing infected conditions did not show significant
increases over non-infected (1.16-fold increase of averaged infected uroepithelial cell conditions over control non-infected
uroepithelial cells). Mann–Whitney U-tests were used for comparisons and SEM bars are shown.
doi: 10.1371/journal.pone.0078013.g003
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Figure 4.  Contact between uroepithelial cells and monocytes drives synergistic and antagonistic biomarker production in
UPEC-infected dual co-cultures.  (A) IL-10 production was synergistic in co-cultures that showed significant increases mediated
by contact between uroepithelial cells and monocytes (compare Ic-Mon/Ep with Ni-Mon/Ep, p ≤ 0.0139). In contrast, the production
of IL-6 (B), GM-CSF (C) and PDGF-BB (D) in insert-containing co-cultures was significantly higher than non-insert co-cultures
(compare Ic-Mon/Ep with Ni-Mon/Ep), revealing antagonistic effects mediated by contact between monocytes and uroepithelial
cells. Statistical comparisons are: + control vs corresponding infected; # insert-containing infected co-culture vs corresponding
infected monoculture; ┴ insert-containing infected co-culture vs no insert infected co-culture, notations are p < 0.05; Mann–Whitney
U-test. (Ic-Ctrl = insert-containing dual co-culture uninfected, Ic-Ep = insert-containing uroepithelial infected, Ic-Mon = insert-
containing monocyte infected, Ic-Mon/Ep = insert-containing monocyte and uroepithelial infected, Ni-Ctrl = no insert co-culture
uninfected, Ni-Mon/Ep = no insert monocyte and uroepithelial infected, Mon-Ctrl = monocyte uninfected, Mon = monocyte infected,
Ep-Ctrl = uroepithelial uninfected, Ep = uroepithelial infected).
doi: 10.1371/journal.pone.0078013.g004
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Figure 5.  UPEC-induced soluble-dependent biomarker responses in dual co-cultures grouped according to biomarker
levels in uroepithelial monocultures.  Experimental Details are as per Figure 4. In this dataset, the most common type of
response was a synergistic increase based on a soluble factor(s) conferred by presence of uroepithelial cells. Statistical
comparisons are: + control vs corresponding infected; # insert-containing infected co-culture vs corresponding infected monoculture;
┴ insert-containing infected co-culture vs no insert infected co-culture, notations are p < 0.05; Mann–Whitney U-test.
doi: 10.1371/journal.pone.0078013.g005
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biomarker in the absence monocytes, e.g. TNF-α, IL-4 and
IFN-γ (Figure 4B, 4C, S2A, S2F).
IL-8 had a unique response pattern whereby infected
uroepithelial cell monocultures produced high levels, but for
monocyte-containing cultures, IL-8 was only produced when in
dual co-culture (Figure 6). Other biomarkers, as shown in
Figure S2 and S3, provide examples of soluble-dependent
interactions that lead to increase based on dual co-cultures
without infection. Figure S2 highlights soluble-dependent
interactions that caused increased expression when the two
cell types were combined in the absence of infection. In many
of these cases, the increases due to infection were additive
based on monoculture levels. Figure S3 also illustrates purely
additive increases of monoculture responses but without
interaction effect from non-infected dual co-cultures (as in S2).
Thus, Figures S2 and S3 indicate infection-dependent and -
independent effects towards biomarker production. As noted,
Table 1 summarizes the infection-independent synergistic
effects between uroepithelial cells and monocytes, and Table 2
lists the significant interactions in these assays for non-infected
co-cultures. Statistical comparisons using ANOVA (Tukey’s
post-hoc) showed similar findings of significant differences
between groups (except with lower P values); the more
conservative results from non-parametric analyses are shown
in Tables/Figures.
Discussion
Refinement of the cell culture model in the current study from
a four cell model to dual co-culture arose with the aim of
identifying cell types that add to the IL-10 response to UPEC.
We showed that the presence of B-cells conferred a basal level
IL-10 response regardless of infection. Monocultures and co-
cultures with T-cells showed no increase in IL-10 due to the
presence of these cells. These data prompted us to remove
both lymphocyte types from the model. Macrophages,
representative of cells pre-existing in the bladder [48], were
also examined and their inclusion in co-culture with
uroepithelial cells promoted a strong increase in the IL-10
response to UPEC. However, the most striking and interesting
finding in this study relates to the discovery of a monocyte, but
not macrophage-dependent synergistic interaction with bladder
uroepithelial cells for UPEC-induced IL-10 production. This
raises the role that monocyte extravasation into tissue may
play [49], where the cells might differentiate in inflammatory
states [50,51]. Their role in cell-cell interactions with
uroepithelial cells in vivo, which might influence bladder
cytokine responses during UTI, is unknown. Mononuclear cell
extravasation through epithelia in other models has previously
been characterised [52,53], and a robust monocyte
inflammatory infiltrate in bladder was recently shown in UPEC
UTI [45]. There is minimal data in the literature pertaining to the
function and specific localization of infiltrating monocytes in the
bladder during UTI and further investigation is required to
elucidate this aspect of UTI pathogenesis. The present study is
the first to show that uroepithelial cell-monocyte interactions
directly modify IL-10 and multiple other cytokine responses
triggered by UPEC. These findings have implications for
understanding bladder responses to UPEC as well as other
uropathogens that induce inflammation in the urinary tract.
The results of this study confirm that monocytes are the main
cell producer of IL-10 in response to UPEC in dual co-culture.
Surprisingly, we found that the presence of uroepithelial cells
significantly enhances this monocyte IL-10 response to UPEC
in a synergistic manner. To our knowledge, there are no prior
studies that have reported synergistic contributions of bladder
uroepithelial cells to antibacterial responses, highlighting the
novelty of these findings. Our qRT-PCR transcriptional
analyses showed an increase of IL-10 mRNA synthesis in
monocyte co-cultures with uroepithelial cells that were
physically separated by inserts. However, uroepithelial cells
showed no significant IL-10 transcriptional activity in response
to UPEC. In corresponding protein quantitation experiments,
we observed a four-fold increase in monocyte-derived IL-10 in
Figure 6.  UPEC-induced soluble-dependent biomarker responses in dual co-cultures grouped according to biomarker
levels in monocyte monocultures.  Experimental Details are as per Figure 4. In this dataset, the least common type of response
was a synergistic increase based on a soluble factor(s) conferred by the presence of monocytes. Statistical comparisons are: +
control vs corresponding infected; # insert-containing infected co-culture vs corresponding infected monoculture; ┴ insert-containing
infected co-culture vs no insert infected co-culture, notations are p < 0.05; Mann–Whitney U-test.
doi: 10.1371/journal.pone.0078013.g006
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Figure 7.  UPEC-induced soluble-dependent biomarker responses in dual co-cultures grouped according to low biomarker
levels in monocultures.  Experimental Details are as per Figure 4. In this dataset, a common type of response was a synergistic
increase based on a soluble factor(s) conferred by the presence of monocytes and uroepithelial cells, with low levels from
monocultures absent in dual co-cultures. Statistical comparisons are: + control vs corresponding infected; # insert-containing infected
co-culture vs corresponding infected monoculture; ┴ insert-containing infected co-culture vs no insert infected co-culture, notations
are p < 0.05; Mann–Whitney U-test.
doi: 10.1371/journal.pone.0078013.g007
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dual co-cultures where the cells were separated by inserts,
compared to an eight-fold increase in co-cultures were
monocytes were not separated from uroepithelial cells. Thus,
not only do monocytes contribute the bulk of the IL-10
response to UPEC, which is consistent with a prior study [12],
but this response occurs in a synergistic, contact-dependent
manner in the presence of uroepithelial cells. Contact-
dependent, synergistic interactions have not previously been
reported for IL-10 responses during infection. Interestingly, we
also noted several biomarkers with response patterns that were
mediated by soluble factors and IL-10 was among these also.
The significance of these soluble-dependent response patterns
is unclear, although it is reasonable to predict that these may
contribute to paracrine antimicrobial signalling mechanisms. In
our study, we have used the term synergy to describe the IL-10
production effect observed in co-cultures. The literature has
indistinct, overlapping definitions of the biological conditions
that define synergistic and priming effects. In this sense, the
effects of a putative soluble-signal(s) between monocytes and
uroepithelial cells could be regarded as a priming strategy.
Table 1. Summary of synergistic and antagonistic effects
between infected uroepithelial cell and monocyte dual co-
cultures compared to monocultures.
UPEC-Infected*
Contact Soluble-Ep Soluble-Mon Soluble-both
IL-10 IL-17 IL-8 IL-1β
IL-6 MCP-1 IL-10 IL-1ra
GM-CSF MIP-1α  IL-2
PDGF-BB MIP-1β  Eotaxin
 RANTES  TNF-α
 IP-10  PDGF-BB
 IL-6   
 GM-CSF   
*. Biomarker levels with a statistically significant difference (not merely additive
effects) compared to biomarker levels in monocultures (Mann-Whitney U-test p <
0.05).
doi: 10.1371/journal.pone.0078013.t001
Table 2. Summary of synergistic and antagonistic effects
between non-infected uroepithelial cell and monocyte dual
co-cultures compared to monocultures.
Non-infected*
Contact Soluble
IL-1ra IL-1ra
IL-2 IL-4
VEGF IL-9
 IL-10
 FGF basic
*. Biomarker levels with a statistically significant difference (not merely additive
effects) compared to biomarker levels in monocultures (Mann-Whitney U-test p <
0.05).
doi: 10.1371/journal.pone.0078013.t002
However, the identity of the soluble-dependent mediator(s) of
enhanced IL-10 production remains to be determined, and thus
synergy provides a more encompassing term than priming, to
represent the sum of soluble- and contact-dependent
responses analysed within this study.
The synergistic interaction between monocytes and
uroepithelial cells for UPEC-triggered IL-10 production
discovered in this study may depend, in part, on pathogen
ligand signalling through receptors such as TLRs. Promotion
and/or antagonism of signalling events for macrophage
cytokine synthesis at the axis of multiple TLRs has been
described [54,55]. A plethora of priming signals may promote
recruitment or cytokine production in mononuclear cells [51,56],
and synergistic effects may provide a basis for broader
complexity of host responses. Many pathogenesis studies on
disease models now use multi-type cellular assays that often
lead to more complex views of host responses. In this sense,
such models may provide a more realistic view of the cell-
cytokine interactions that occur in situ, with positive and
negative feedback loops based around sequential multifaceted
immunological events. The data provided in this study suggest
that such feedback loops are relevant to anti-UPEC responses.
Our BioPlex analysis provides overarching and broad insight
into the ample biomarker responses to UPEC beyond IL-10,
that are mediated by uroepithelial cell-monocyte interactions.
Multiple biomarkers were shown to depend on specific cell
arrangements for their peak production in response to UPEC,
and we discovered different degrees of contact- and soluble-
dependency for biomarker production in a mixture of
synergistic and antagonistic interactions. For example, UPEC-
induced IL-10 production peaked as a contact-dependent,
synergistic response, while IL-6 and GM-CSF production was
also contact-dependent but was antagonistic, driven by the
presence of the two cell types. PDGF-BB exhibited both
soluble-dependent synergy (insert dual co-cultures compared
to monocultures), and contact-dependent antagonism (insert
versus no-insert dual co-cultures). When grouped according to
the contact dependency of the interaction these data reveal
that uroepithelial cells can augment biomarker production in
response to UPEC when there is a monocyte-derived soluble
factor produced. Here, monocytes could trigger uroepithelial
cells to produce the cytokine, or a soluble signal(s) from
infected uroepithelial cells could prompt monocytes to produce
the cytokine, similar to IL-10 but without contact dependency.
We note that development of tight-junction uroepithelial
monolayers were avoided in the current study to mimic
conditions of uroepithelial cell exfoliation in UTI, as reviewed
elsewhere [57].
Another cytokine of interest, due to its known role in UPEC
UTI, is G-CSF. High levels of G-CSF were detected in
uroepithelial cell monocultures and dual co-cultures in this
study, but we did not detect a consistent increase in response
to infection, which contrasts with the murine model of UPEC
UTI [58]. This difference could relate to the human cell-based
system that we have used in contrast to the murine model;
distinct differences between human and murine macrophages
to UPEC in terms of cytokine responses have been reported
[47]. Other experimental differences such as time of exposure,
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UPEC challenge strain, and/or use of fimbriae-enriched
bacterial cultures could also explain the lack of infection-
induced G-CSF response in the current in vitro study compared
to the murine UTI model. It is also plausible that cell types
excluded from the current work (e.g. neutrophils, dendritic cells,
mast cells) may contribute to responses known to occur in vivo,
which is a limitation of the current study by-design.
Intimate cooperation between cells of the innate immune
system such as epithelial cells, monocytes and neutrophils and
their soluble factors is critical for antimicrobial defence. Such
cooperative interactions have been demonstrated in several
recent in vitro and ex vivo studies of responses to several
pathogens; in Mycobacterium spp. infection, soluble factors
produced by infected epithelial cells activate neutrophils for
diapedesis, and infected neutrophils activate macrophages
[59,60]; in Bordetella pertussis infection, cell contact rather
than production of soluble factors is required for generating
suppressive host responses [61]; Leishmania braziliensis-
infected human monocytes produce soluble factors including
IL-10 and C-X-C motif chemokine 10 (CXCL10) (also known as
Interferon gamma-induced protein 10; IP-10) that activate and
enhance the expression of cytokines in non-infected
monocytes [62]; in an in vitro co-culture system of Helicobacter
pylori infection used to model the in vivo situation, cooperative
interactions between epithelial cells and monocytes related to
cathepsin X and cytokine expression are modulated by the H.
pylori virulence factor CagA [63]; in Burkholderia pseudomallei
infection, macrophage-lymphocyte cooperative interactions
mediate antibacterial activity [64]. Other cooperative cell-cell
responses to various pathogens have recently been reviewed
[32]. The results of the current study extend our knowledge of
these cell-cell interactions in response to UPEC by defining
novel cooperative effects of uroepithelial cells and monocytes
to drive IL-10 and other biomarker responses. Precisely how
the synergistic and antagonistic responses described in this
study might influence the pathogenesis of UPEC UTI will
require further study and is an area in much need of
investigation.
Supporting Information
Figure S1.  Control cell culture levels with basal level
expression of IL-10 not contributing to synergistic effects.
(A) B-cells provide only a higher basal level of IL-10 in co-
cultures when present (Non-infected vs. infected co-culture, § p
≤ 0.001; Presence/absence of B-cells comparing Non-infected,
or infected co-cultures, * p ≤ 0.001; SEM bars). (B) Additional
non-infected single and co-cultures used in comparison to
infected co-cultures from Figure 1A. (C) Non-infected and
infected monocultures of uroepithelial cells in comparison to
data from Figure 2 (not significant).
(TIF)
Figure S2.  Basal-level biomarker production in non-
infected monocultures can contribute to infection-
independent synergistic effects in dual co-cultures. Some
dual co-cultures demonstrated a synergistic increase of
cytokine production when the two cell types were incubated
together, but the only infected condition increase came from
additive levels seen in monocultures (Statistical comparisons
are: + control vs corresponding infected; # insert-containing
infected co-culture vs corresponding infected monoculture,
notations are p < 0.05; Mann–Whitney U-test).
(TIF)
Figure S3.  Basal-level biomarker production in
monocultures can be expressed as additive effects in dual
co-cultures. The remaining cytokines investigated for
induction in the dual/monocultures showed a purely additive
effect, based on monoculture cytokine production, or no
significant increase at all (Statistical comparisons are: + control
vs corresponding infected; # insert-containing infected co-
culture vs corresponding infected monoculture, notations are p
< 0.05; Mann–Whitney U-test).
(TIFF)
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